ArticleInvestigative ophthalmology & visual science2013

A1120, a nonretinoid RBP4 antagonist, inhibits formation of cytotoxic bisretinoids in the animal model of enhanced retinal lipofuscinogenesis.

Nicoleta Dobri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.